TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $65

Benzinga Newsdesk www.benzinga.com Positive 69.4%

Neg 0% Neu 0% Pos 69.4%

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $60 to $65.